News Releases

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Email Alerts

Year All Years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go

Advanced Search

Keywords

  Search Headlines Only

From

To

Asset Types

 Photos  Video  Audio  Documents  Events  Standard

 Basic Search

• Oct 14, 2008

  Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
• Oct 14, 2008

  Insmed to Seek Shareholder Approval for Reverse Split
• Sep 23, 2008

  Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants
• Sep 15, 2008

  Insmed to Present at Biosimilars 2008 Conference
• Sep 4, 2008

  Insmed to Present at BioPharm Asia 2008 Conference
• Sep 3, 2008

  NASDAQ Hearing Panel Grants Insmed Request for Continued Listing on the NASDAQ Stock Market
• Aug 8, 2008

  Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
• Jul 28, 2008

  Jim Miller, Ph.D. Joins Insmed Therapeutic Proteins as Vice President of Process Development
• Jul 25, 2008

  Insmed to Host Second Quarter 2008 Conference Call
• Jul 25, 2008

  Insmed CEO to Present at Drug Discovery & Development Conference

Show 5102550100 per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

Sign Up

View the latest Insmed Investor Presentation

Download